AI assistant
Sending…
HALLIBURTON CO — Director's Dealing 2017
Dec 8, 2017
30269_dirs_2017-12-08_25d41b27-d907-42c6-9cbc-3bf13f30c3ba.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HALLIBURTON CO (HAL)
CIK: 0000045012
Period of Report: 2017-12-06
Reporting Person: Voyles Robb L. (EVP, Sec & General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-12-06 | Common Stock | A | 20600 | $43.38 | Acquired | 227482.466 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-12-06 | Option to Buy Common Stock | $43.38 | A | 34300 | Acquired | 2027-12-06 | Common Stock (34300) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option to Buy Common Stock | $53.54 | 2026-12-07 | Common Stock (30500) | 30500 | Direct |
| Option to Buy Common Stock | $38.95 | 2025-12-02 | Common Stock (41300) | 41300 | Direct |
| Option to Buy Common Stock | $40.75 | 2024-12-03 | Common Stock (41300) | 41300 | Direct |
| Option to Buy Common Stock | $49.82 | 2023-09-16 | Common Stock (100000) | 100000 | Direct |
Footnotes
F1: Shares awarded pursuant to the Halliburton Company Stock and Incentive Plan. Said Plan provides for the surrender of common stock to the Issuer to satisfy withholding tax obligations.
F2: On December 6, 2017, the closing price of Halliburton Company's Common Stock on the New York Stock Exchange was $43.38.
F3: The options awarded become exercisable on each of the first, second and third anniversaries of the grant in cumulative increments of one-third each of the number of shares subject to the grant.
More from HALLIBURTON CO
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 20
Major Shareholding Notification
2026
Apr 30
Interim / Quarterly Report
2026
Apr 24
Regulatory Filings
2026
Apr 21
Major Shareholding Notification
2026
Apr 6
Proxy Solicitation & Information Statement
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 31
Director's Dealing
2026
Mar 30
Regulatory Filings
2026
Mar 27